A B King

Summary

Publications

  1. doi request reprint Liraglutide achieves A1C targets more often than sitagliptin or exenatide when added to metformin in patients with type 2 diabetes and a baseline A1C <8.0%
    Allen B King
    Diabetes Care Center, Salinas, CA 93901, USA
    Endocr Pract 19:64-72. 2013
  2. ncbi request reprint The number of basal rates required to achieve near-normal basal glucose control in pump-treated type 2 diabetes
    Allen B King
    Diabetes Care Center, Salinas, California 93901, USA
    Diabetes Technol Ther 14:900-3. 2012
  3. doi request reprint Contribution of the dawn phenomenon to the fasting and postbreakfast hyperglycemia in type 1 diabetes treated with once-nightly insulin glargine
    Allen B King
    Diabetes Care Center, Salinas, California 93901, USA
    Endocr Pract 18:558-62. 2012
  4. doi request reprint How much do I give? Dose estimation formulas for once-nightly insulin glargine and premeal insulin lispro in type 1 diabetes mellitus
    Allen B King
    Diabetes Care Center, Salinas, California 93901, USA
    Endocr Pract 18:382-6. 2012
  5. pmc Continuous glucose monitoring-guided insulin dosing in pump-treated patients with type 1 diabetes: a clinical guide
    Allen B King
    Diabetes Care Center, Salinas, California 93901, USA
    J Diabetes Sci Technol 6:191-203. 2012
  6. doi request reprint How much do I give? Reevaluation of insulin dosing estimation formulas using continuous glucose monitoring
    Allen B King
    Diabetes Care Center, Salinas, California 93901, USA
    Endocr Pract 16:428-32. 2010
  7. ncbi request reprint Minimal reduction in insulin dosage with pramlintide therapy when pretreatment near-normal glycemia is established and square-wave meal bolus is used
    Allen B King
    The Diabetes Care Center, The University of California San Francisco, Salinas, California, San Francisco, California 93901, USA
    Endocr Pract 15:229-33. 2009
  8. pmc No higher dose requirements with insulin detemir than glargine in type 2 diabetes: a crossover, double-blind, and randomized study using continuous glucose monitoring
    Allen B King
    Diabetes Care Center, Salinas, California, USA
    J Diabetes Sci Technol 4:151-4. 2010
  9. doi request reprint Once-daily insulin detemir is comparable to once-daily insulin glargine in providing glycaemic control over 24 h in patients with type 2 diabetes: a double-blind, randomized, crossover study
    A B King
    Diabetes Care Center, Salinas, CA, USA
    Diabetes Obes Metab 11:69-71. 2009
  10. ncbi request reprint Basal bolus dosing: a clinical experience
    Allen B King
    Diabetes Care Center, Salinas, California, USA
    Curr Diabetes Rev 1:215-20. 2005

Detail Information

Publications19

  1. doi request reprint Liraglutide achieves A1C targets more often than sitagliptin or exenatide when added to metformin in patients with type 2 diabetes and a baseline A1C <8.0%
    Allen B King
    Diabetes Care Center, Salinas, CA 93901, USA
    Endocr Pract 19:64-72. 2013
    ..Compare the safety and efficacy of liraglutide to that of sitagliptin or exenatide as add-on to metformin in patients with type 2 diabetes (T2D) and glycated hemoglobin (A1C) <8.0%...
  2. ncbi request reprint The number of basal rates required to achieve near-normal basal glucose control in pump-treated type 2 diabetes
    Allen B King
    Diabetes Care Center, Salinas, California 93901, USA
    Diabetes Technol Ther 14:900-3. 2012
    ..Using daily continuous glucose monitoring (CGM)-directed titration, this premise was re-evaluated at near-normal glycemic control...
  3. doi request reprint Contribution of the dawn phenomenon to the fasting and postbreakfast hyperglycemia in type 1 diabetes treated with once-nightly insulin glargine
    Allen B King
    Diabetes Care Center, Salinas, California 93901, USA
    Endocr Pract 18:558-62. 2012
    ..To observe the effect of the dawn phenomenon on basal glucose and postbreakfast hyperglycemia in patients with type 1 diabetes treated with once-nightly insulin glargine and premeal insulin lispro...
  4. doi request reprint How much do I give? Dose estimation formulas for once-nightly insulin glargine and premeal insulin lispro in type 1 diabetes mellitus
    Allen B King
    Diabetes Care Center, Salinas, California 93901, USA
    Endocr Pract 18:382-6. 2012
    ..To evaluate the mathematical relationships between dosing factors in type 1 diabetic patients using multiple daily injections...
  5. pmc Continuous glucose monitoring-guided insulin dosing in pump-treated patients with type 1 diabetes: a clinical guide
    Allen B King
    Diabetes Care Center, Salinas, California 93901, USA
    J Diabetes Sci Technol 6:191-203. 2012
    ..This is a guide and, as such, is not meant to replace clinical judgment. Also, these dosing approaches apply only to those patients on pump therapy. They do not necessarily carry over to those patients treated with basal analog insulin...
  6. doi request reprint How much do I give? Reevaluation of insulin dosing estimation formulas using continuous glucose monitoring
    Allen B King
    Diabetes Care Center, Salinas, California 93901, USA
    Endocr Pract 16:428-32. 2010
    ....
  7. ncbi request reprint Minimal reduction in insulin dosage with pramlintide therapy when pretreatment near-normal glycemia is established and square-wave meal bolus is used
    Allen B King
    The Diabetes Care Center, The University of California San Francisco, Salinas, California, San Francisco, California 93901, USA
    Endocr Pract 15:229-33. 2009
    ....
  8. pmc No higher dose requirements with insulin detemir than glargine in type 2 diabetes: a crossover, double-blind, and randomized study using continuous glucose monitoring
    Allen B King
    Diabetes Care Center, Salinas, California, USA
    J Diabetes Sci Technol 4:151-4. 2010
    ..We now report the dose comparison observed within this randomized, double-blind, crossover study...
  9. doi request reprint Once-daily insulin detemir is comparable to once-daily insulin glargine in providing glycaemic control over 24 h in patients with type 2 diabetes: a double-blind, randomized, crossover study
    A B King
    Diabetes Care Center, Salinas, CA, USA
    Diabetes Obes Metab 11:69-71. 2009
    ..3 and 26.6 units/day, respectively, p = 0.837). In this study, once-daily dosing of insulin detemir provided 24-h glycaemic control similar to that of insulin glargine in patients with type 2 diabetes...
  10. ncbi request reprint Basal bolus dosing: a clinical experience
    Allen B King
    Diabetes Care Center, Salinas, California, USA
    Curr Diabetes Rev 1:215-20. 2005
    ..Daily consecutive intensive glucose evaluations using a continuous glucose monitoring system and corresponding dosage adjustments may offer an even better tool for insulin dosing selection...
  11. ncbi request reprint Evaluation of a patient education booklet (SimpleStart) effect on postprandial glucose control in type 2 diabetes
    Allen B King
    Diabetes Care Center, Salinas, California 93901, USA
    Diabetes Technol Ther 9:241-5. 2007
    ..We evaluated SimpleStart in a controlled, randomized, prospective trial using continuous glucose monitoring (CGM)...
  12. ncbi request reprint Exploring methods to extend the reach of diabetes specialist expertise into primary care clinics
    Allen King
    Diabetes Care Center, 1260 South Main Street, Suite 201, Salinas, CA 93901, USA
    Diabetes Educ 32:525-30. 2006
    ..Hallmarks of the program include dissemination of diabetes care through midlevel practitioners in primary care offices, using standardized algorithms, and computer-assisted guidance of therapy...
  13. doi request reprint Comparison of the post-meal glucose response to different insulin bolus waveforms in insulin pump- and pre-meal pramlintide-treated type 1 diabetes patients
    Allen B King
    Diabetes Care Center, Salinas, California 93901, USA
    Diabetes Technol Ther 12:105-8. 2010
    ..The MC was a "square" (SQ) wave combined with a "standard" (ST) bolus that was delayed 1 h into the mealtime...
  14. ncbi request reprint Lipid response to pioglitazone in diabetic patients: clinical observations from a retrospective chart review
    Allen B King
    Diabetes Care Center, 1119 Pajaro Street, Salinas, CA 93901, USA
    Diabetes Technol Ther 4:145-51. 2002
    ..The greatest improvements occurred in patients with the worst baseline lipid levels, and benefits were seen regardless of whether patients were receiving concurrent statin therapy...
  15. doi request reprint Evaluation of a diabetes specialist-guided primary care diabetes treatment program
    Allen B King
    Diabetes Care Center, Salinas, CA 93901, USA
    J Am Acad Nurse Pract 21:24-30. 2009
    ....
  16. ncbi request reprint Daily glucose trend analyses and treatment adjustments using the continuous glucose monitoring system (CGMS, Medtronic MiniMed): "tweaking"
    Allen B King
    Diabetes Technol Ther 6:297. 2004
  17. ncbi request reprint Clinical observations of exenatide treatment
    Allen B King
    Diabetes Care 29:1984. 2006
  18. ncbi request reprint A comparison of basal insulin delivery: continuous subcutaneous insulin infusion versus glargine
    Allen B King
    Diabetes Care 26:1322. 2003
  19. ncbi request reprint Comparison of glycemic and lipid response to pioglitazone treatment in Mexican-Americans and non-Hispanic Caucasians with type 2 diabetes
    Allen B King
    Diabetes Care 26:245-6. 2003